<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05073952</url>
  </required_header>
  <id_info>
    <org_study_id>KM001</org_study_id>
    <nct_id>NCT05073952</nct_id>
  </id_info>
  <brief_title>Keratized Mucosa in CG Implant Placement: CTG vs Flapless</brief_title>
  <official_title>Width of Keratinazed Mucosa in Immediately Loaded Posterior Implant Restorations Treated With Different Surgical Approaches: Randomized Clinical Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study will evaluate the difference in terms of keratinazed mucosa (KM) in&#xD;
      computer guided implant placement with immediate loading, comparing a flapless approach to&#xD;
      flap surgery with connective tissue graft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 18, 2021</start_date>
  <completion_date type="Anticipated">June 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>two groups will be compared with different treatment</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>surgical treatment will be conducted with surgeon-investigator and patient unblinded. the outcome assessor will be blinded as primary outcome measurements will be taken on a computer.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Widht of Keratinized mucosa</measure>
    <time_frame>2-4-8-12-24 weeks - 1-2-3-4-5 years</time_frame>
    <description>variation of keratized mucosa from t0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>implant survival</measure>
    <time_frame>1-2-3-4-5 years</time_frame>
    <description>Implant in function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>marginal bone loss</measure>
    <time_frame>1-2-3-4-5 years</time_frame>
    <description>variation of marginal bone loss over time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vas Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>Prom: patient VAS scale for post-operative pain, from 0 to 10, where 10 is higher and 0 is minimum.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Time</measure>
    <time_frame>day 1</time_frame>
    <description>surgical time differences between the two groups</description>
  </other_outcome>
  <other_outcome>
    <measure>prosthetic complications</measure>
    <time_frame>1-2-3-4-5 years</time_frame>
    <description>number and type of prosthetic complications over time</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">44</enrollment>
  <condition>Variation of Keratinized Mucosa After Implant Surgery</condition>
  <arm_group>
    <arm_group_label>Connective tissue graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient in this group will be treated with a flap and a connective tissue graft at the moment of implant placement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Flapess</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient in this group will be treated with a flapless approach at the moment of implant placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Connective tissue graft</intervention_name>
    <description>Implants will be placed with a flap and a connective tissue graft.</description>
    <arm_group_label>Connective tissue graft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Flapless</intervention_name>
    <description>Implants will be placed with a flapless approach</description>
    <arm_group_label>Flapess</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18+&#xD;
&#xD;
          -  Patients with partial edentulism in the posterior region (4-7) upper or lower for at&#xD;
             least 3 months&#xD;
&#xD;
          -  Patient whose tomographic examination shows adequate bone volumes for computer guided&#xD;
             placement of a standard diameter implant (&gt; 3.5 mm) without the need for bone&#xD;
             regeneration procedures&#xD;
&#xD;
          -  Patients who have accepted informed consent and participation in the study&#xD;
&#xD;
          -  Patients who do not have exclusion criteria&#xD;
&#xD;
        Eclusion Criteria&#xD;
&#xD;
          -  Patients who refuse to co-operate&#xD;
&#xD;
          -  Systemic conditions of exclusion:&#xD;
&#xD;
               -  Medical conditions requiring prolonged use of steroids&#xD;
&#xD;
               -  Severe hemophilia&#xD;
&#xD;
               -  In therapy with intravenous bisphosphonates&#xD;
&#xD;
               -  History of white blood cell dysfunction or deficiency&#xD;
&#xD;
               -  History of head and neck radiotherapy or chemotherapy&#xD;
&#xD;
               -  History of kidney failure&#xD;
&#xD;
               -  Pregnant or breastfeeding patient&#xD;
&#xD;
               -  History of uncontrolled endocrine disorders&#xD;
&#xD;
               -  Physical handicaps that hinder proper oral hygiene&#xD;
&#xD;
               -  Use of experimental devices or drugs within 30 days prior to implant placement&#xD;
                  surgery&#xD;
&#xD;
               -  Alcoholism or drug abuse&#xD;
&#xD;
               -  Smokers of&gt; 10 cigarettes per day or the equivalent cigar or&gt; 10 tobacco-based&#xD;
                  chewings per day&#xD;
&#xD;
               -  Conditions or circumstances that prevent the completion of participation in the&#xD;
                  study or interfere with the analysis of the study results&#xD;
&#xD;
        Local exclusion conditions:&#xD;
&#xD;
          -  Local inflammation, including untreated periodontitis&#xD;
&#xD;
          -  Patients with erosive lichen planus&#xD;
&#xD;
          -  History of local radiation therapy&#xD;
&#xD;
          -  Presence of bone lesions&#xD;
&#xD;
          -  Unhealed extraction sites&#xD;
&#xD;
          -  History of bone reconstruction and bone grafting techniques in the sites where the&#xD;
             implants are to be inserted&#xD;
&#xD;
          -  Bruxism&#xD;
&#xD;
          -  Bleeding index&gt; 30% and number of pockets&gt; 5mm greater than 10&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinica Odontoiatrica Giorgio Vogel</name>
      <address>
        <city>Milan</city>
        <state>MI</state>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milan</investigator_affiliation>
    <investigator_full_name>Stefano Storelli</investigator_full_name>
    <investigator_title>Reasearcher</investigator_title>
  </responsible_party>
  <keyword>dental implant</keyword>
  <keyword>Keratinized mucosa</keyword>
  <keyword>Connective tissue graft</keyword>
  <keyword>flapless implant placement</keyword>
  <keyword>Computer guided implantology</keyword>
  <keyword>Immediate loading</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

